These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30514966)

  • 21. Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: Qualitative effects on electrophysiological responses to drugs.
    Otsuji TG; Minami I; Kurose Y; Yamauchi K; Tada M; Nakatsuji N
    Stem Cell Res; 2010 May; 4(3):201-13. PubMed ID: 20199896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes.
    Shinozawa T; Nakamura K; Shoji M; Morita M; Kimura M; Furukawa H; Ueda H; Shiramoto M; Matsuguma K; Kaji Y; Ikushima I; Yono M; Liou SY; Nagai H; Nakanishi A; Yamamoto K; Izumo S
    Stem Cell Reports; 2017 Feb; 8(2):226-234. PubMed ID: 28111276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Electrophysiological identification of human induced pluripotent stem cell-derived cardiomyocytes].
    Zhang HY; Zhang TT; Machuki JO; Wu LJ; Sun H
    Sheng Li Xue Bao; 2018 Jun; 70(3):281-286. PubMed ID: 29926069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The assessment of electrophysiological activity in human-induced pluripotent stem cell-derived cardiomyocytes exposed to dimethyl sulfoxide and ethanol by manual patch clamp and multi-electrode array system.
    Hyun SW; Kim BR; Hyun SA; Seo JW
    J Pharmacol Toxicol Methods; 2017 Sep; 87():93-98. PubMed ID: 28377112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiomyocyte culture as a highly sensitive system for testing pharmacological activity of specific bradycardic agents].
    Neverova ME; Mkrtumova NA; Fidelina OV; Adamskaia EI; Tsorin IB; Chichkanov GG; Chudakov LI
    Eksp Klin Farmakol; 2006; 69(5):24-6. PubMed ID: 17153961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2.
    Maizels L; Huber I; Arbel G; Tijsen AJ; Gepstein A; Khoury A; Gepstein L
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28630169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes.
    Caspi O; Itzhaki I; Kehat I; Gepstein A; Arbel G; Huber I; Satin J; Gepstein L
    Stem Cells Dev; 2009; 18(1):161-72. PubMed ID: 18510453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology.
    Hayakawa T; Kunihiro T; Ando T; Kobayashi S; Matsui E; Yada H; Kanda Y; Kurokawa J; Furukawa T
    J Mol Cell Cardiol; 2014 Dec; 77():178-91. PubMed ID: 25257913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
    Yang X; Papoian T
    J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational models of ventricular- and atrial-like human induced pluripotent stem cell derived cardiomyocytes.
    Paci M; Hyttinen J; Aalto-Setälä K; Severi S
    Ann Biomed Eng; 2013 Nov; 41(11):2334-48. PubMed ID: 23722932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid and Glucocorticoid Hormones Promote Functional T-Tubule Development in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Parikh SS; Blackwell DJ; Gomez-Hurtado N; Frisk M; Wang L; Kim K; Dahl CP; Fiane A; Tønnessen T; Kryshtal DO; Louch WE; Knollmann BC
    Circ Res; 2017 Dec; 121(12):1323-1330. PubMed ID: 28974554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy.
    Carlson C; Koonce C; Aoyama N; Einhorn S; Fiene S; Thompson A; Swanson B; Anson B; Kattman S
    J Biomol Screen; 2013 Dec; 18(10):1203-11. PubMed ID: 24071917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary cardiac manifestation of autosomal dominant polycystic kidney disease revealed by patient induced pluripotent stem cell-derived cardiomyocytes.
    Lee JJ; Cheng SJ; Huang CY; Chen CY; Feng L; Hwang DY; Kamp TJ; Chen HC; Hsieh PCH
    EBioMedicine; 2019 Feb; 40():675-684. PubMed ID: 30639418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of appropriate stage of human-induced pluripotent stem cell-derived cardiomyocytes for drug screening and pharmacological evaluation in vitro.
    Shinozawa T; Imahashi K; Sawada H; Furukawa H; Takami K
    J Biomol Screen; 2012 Oct; 17(9):1192-203. PubMed ID: 22706346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of cardiotoxicity assessment using calcium transient in human induced pluripotent stem cell-derived cardiomyocytes.
    Watanabe H; Honda Y; Deguchi J; Yamada T; Bando K
    J Toxicol Sci; 2017; 42(4):519-527. PubMed ID: 28717111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtype-specific promoter-driven action potential imaging for precise disease modelling and drug testing in hiPSC-derived cardiomyocytes.
    Chen Z; Xian W; Bellin M; Dorn T; Tian Q; Goedel A; Dreizehnter L; Schneider CM; Ward-van Oostwaard D; Ng JK; Hinkel R; Pane LS; Mummery CL; Lipp P; Moretti A; Laugwitz KL; Sinnecker D
    Eur Heart J; 2017 Jan; 38(4):292-301. PubMed ID: 28182242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment.
    Clements M; Millar V; Williams AS; Kalinka S
    Toxicol Sci; 2015 Nov; 148(1):241-60. PubMed ID: 26259608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational investigation of drug action on human-induced stem cell-derived cardiomyocytes.
    Frotscher R; Koch JP; Staat M
    J Biomech Eng; 2015 Jul; 137(7):. PubMed ID: 25807216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An integrated platform for simultaneous multi-well field potential recording and Fura-2-based calcium transient ratiometry in human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes.
    Rast G; Weber J; Disch C; Schuck E; Ittrich C; Guth BD
    J Pharmacol Toxicol Methods; 2015; 75():91-100. PubMed ID: 25921432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
    Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
    Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.